Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
58.61 USD | +2.20% | +0.50% | -6.37% |
Financials (USD)
Sales 2024 * | 1,136 M | Sales 2025 * | 1,162 M | Capitalization | 2,908 M |
---|---|---|---|---|---|
Net income 2024 * | 216 M | Net income 2025 * | 230 M | EV / Sales 2024 * | 2,56x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2,50x |
P/E ratio 2024 * | 13,6x | P/E ratio 2025 * | 12,7x | Employees | 560 |
Yield 2024 * | - | Yield 2025 * | - | Free-Float | 88.64% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
1 day | +2.20% | ||
1 week | +0.50% | ||
Current month | +2.20% | ||
1 month | -1.60% | ||
3 months | +0.41% | ||
6 months | +0.19% | ||
Current year | -6.37% |
1 week
56.61
58.75

1 month
56.61
60.32

Current year
52.90
68.54

1 year
52.90
68.54

3 years
34.26
68.54

5 years
26.25
68.54

10 years
24.94
68.54

Managers | Title | Age | Since |
---|---|---|---|
Ronald Lombardi
CEO | Chief Executive Officer | 59 | 2010 |
Christine Sacco
DFI | Director of Finance/CFO | 48 | 2016 |
Jeff Zerillo
COO | Chief Operating Officer | 62 | 2018 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sheila Hopkins
BRD | Director/Board Member | 67 | 2015 |
Celeste Clark
BRD | Director/Board Member | 70 | 2021 |
Dawn Zier
BRD | Director/Board Member | 58 | 2020 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.42% | 232 M€ | -9.17% | ||
2.84% | 193 M€ | -13.11% | ||
2.26% | 9 M€ | 0.00% | - | |
1.44% | 9 M€ | +8.29% | ||
1.25% | 161 M€ | -8.16% |
Date | Price | Change | Volume |
---|---|---|---|
23-12-01 | 58.61 | +2.20% | 243,418 |
23-11-30 | 57.35 | +0.61% | 205,699 |
23-11-29 | 57.00 | -0.23% | 183,438 |
23-11-28 | 57.13 | -1.58% | 151,565 |
23-11-27 | 58.05 | -0.46% | 162,622 |
Delayed Quote Nyse, December 01, 2023 at 04:00 pm EST
More quotes
Prestige Consumer Healthcare Inc. is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club and e-commerce stores in North America (the United States and Canada) and in Australia and certain other international markets. The Company operates through two segments: North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands include Monistat and Summer's Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart treatments, Little Remedies pediatric over-the-counter products, Boudreaux's Butt Paste diaper rash ointments, Nix lice treatment, Debrox earwax remover, and others.
Sector
Pharmaceuticals
Calendar
2024-01-31
- Q3 2024 Earnings Release (Projected)
Trading Rating :
Investor Rating :
ESG Refinitiv :
B-
Sell
Buy

Mean consensus
BUY
Number of Analysts
7
Last Close Price
58.61USD
Average target price
71.50USD
Spread / Average Target
+21.99%
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.37% | 2 908 M $ | |
+59.64% | 525 B $ | |
-10.34% | 381 B $ | |
-6.75% | 262 B $ | |
-11.26% | 253 B $ | |
-17.52% | 221 B $ | |
+2.14% | 202 B $ | |
-9.09% | 200 B $ | |
-43.58% | 163 B $ | |
+3.74% | 146 B $ |